Fueled by this prospect, Nakayama et al. [65] were the first that revealed a positive linkage between increased CK19 serum levels and low survival rate in patients with IPF and CVD-IP suggesting a potential role for this tumour marker in reflecting the severity of the lung injury and the disease prognosis. The gene discussed is KRT19; the disease is idiopathic pulmonary fibrosis.